MAPT and Parkinson disease: The description of PD-ALS clinical complex supports the hypothesis of there being common neuropathological pathways related to the frequent co-occurrence of αSyn and tau aggregation in such brains, suggesting the synergistic interaction of these (and other) proteins in determining the neurodegenerative process.